3002.49.00.50/Zika Virus Vaccine Candidate/Canada

Zika Virus Vaccine Candidate from Canada

mRNA-based or DNA vaccine platform for Zika flavivirus prevention, in clinical stages. Fits HTS 3002.49.0050 as other virus culture-derived prophylactic product via biotech processes.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Classify as gene therapy if applicable; special USDA permits for vectors

• Document trial phase and IRB approval; frozen shipment standard

Zika Virus Vaccine Candidate from Canada — Import Duty Rate | HTS 3002.49.00.50